Clinical Clarity

One Molecule at a Time

Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.

Learn More

Clinical Lab Testing Services
Clinical Diagnostics System

Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Press Releases

  • May 21, 2015
    Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMCTM) Technology
  • April 30, 2015
    Singulex Announces Partnership with The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers

Upcoming Events

  • Jul 18, 2015 - Jul 23, 2015:
    Alzheimer's Association International Conference(AAIC)
    Exhibit: Booth #344 Washington, DC
  • Jul 26, 2015 - Jul 30, 2015:
    Atlanta, Georgia